Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
psoriasis; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of psoriasis in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced psoriasis (Verbatim: psoriasis). The outcome of the psoriasis was not reported. It was unknown if the reporter considered the psoriasis to be related to Shingles vaccine. It was unknown if the company considered the psoriasis to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 26-MAR-2025 This case was reported by a patient via interactive digital media. The patient never had psoriasis until got the shingles vaccine, just saying.